Cargando…
Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms
BACKGROUND: The prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM) is high, though its severity is often underestimated. Our aim is to provide an estimate of the prevalence of severe NAFLD in T2DM and identify its major predictors. METHODS: T2DM p...
Autores principales: | Bellan, Mattia, Colletta, Cosimo, Barbaglia, Matteo Nazzareno, Salmi, Livia, Clerici, Roberto, Mallela, Venkata Ramana, Castello, Luigi Mario, Saglietti, Giuseppe, Carnevale Schianca, Gian Piero, Minisini, Rosalba, Pirisi, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834828/ https://www.ncbi.nlm.nih.gov/pubmed/31694082 http://dx.doi.org/10.4093/dmj.2018.0201 |
Ejemplares similares
-
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients
por: De Benedittis, Carla, et al.
Publicado: (2020) -
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
por: Smirne, Carlo, et al.
Publicado: (2020) -
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment
por: Carissimi, Francesca, et al.
Publicado: (2021) -
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon
por: Barbaglia, Matteo Nazzareno, et al.
Publicado: (2022) -
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein
por: Rizzi, Manuela, et al.
Publicado: (2022)